Standard
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia. / Malani, Disha; Yadav, Bhagwan; Kumar, Ashwini; Potdar, Swapnil; Kontro, Mika; Kankainen, Matti; Javarappa, Komal K.; Porkka, Kimmo; Wolf, Maija; Aittokallio, Tero; Wennerberg, Krister; Heckman, Caroline A.; Murumägi, Astrid; Kallioniemi, Olli.
In:
Leukemia, Vol. 34, 2020, p. 2780-2784.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Malani, D, Yadav, B, Kumar, A, Potdar, S, Kontro, M, Kankainen, M, Javarappa, KK, Porkka, K, Wolf, M, Aittokallio, T
, Wennerberg, K, Heckman, CA, Murumägi, A & Kallioniemi, O 2020, '
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia',
Leukemia, vol. 34, pp. 2780-2784.
https://doi.org/10.1038/s41375-020-0978-7APA
Malani, D., Yadav, B., Kumar, A., Potdar, S., Kontro, M., Kankainen, M., Javarappa, K. K., Porkka, K., Wolf, M., Aittokallio, T.
, Wennerberg, K., Heckman, C. A., Murumägi, A., & Kallioniemi, O. (2020).
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.
Leukemia,
34, 2780-2784.
https://doi.org/10.1038/s41375-020-0978-7Vancouver
Malani D, Yadav B, Kumar A, Potdar S, Kontro M, Kankainen M et al.
KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.
Leukemia. 2020;34:2780-2784.
https://doi.org/10.1038/s41375-020-0978-7Author
Malani, Disha ; Yadav, Bhagwan ; Kumar, Ashwini ; Potdar, Swapnil ; Kontro, Mika ; Kankainen, Matti ; Javarappa, Komal K. ; Porkka, Kimmo ; Wolf, Maija ; Aittokallio, Tero ; Wennerberg, Krister ; Heckman, Caroline A. ; Murumägi, Astrid ; Kallioniemi, Olli. / KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia. In: Leukemia. 2020 ; Vol. 34. pp. 2780-2784.
Bibtex
@article{891d71ea4d1a40cba1c9ac1be975c26b,
title = "KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia",
author = "Disha Malani and Bhagwan Yadav and Ashwini Kumar and Swapnil Potdar and Mika Kontro and Matti Kankainen and Javarappa, {Komal K.} and Kimmo Porkka and Maija Wolf and Tero Aittokallio and Krister Wennerberg and Heckman, {Caroline A.} and Astrid Murum{\"a}gi and Olli Kallioniemi",
year = "2020",
doi = "10.1038/s41375-020-0978-7",
language = "English",
volume = "34",
pages = "2780--2784",
journal = "Leukemia",
issn = "0887-6924",
publisher = "nature publishing group",
}
RIS
TY - JOUR
T1 - KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia
AU - Malani, Disha
AU - Yadav, Bhagwan
AU - Kumar, Ashwini
AU - Potdar, Swapnil
AU - Kontro, Mika
AU - Kankainen, Matti
AU - Javarappa, Komal K.
AU - Porkka, Kimmo
AU - Wolf, Maija
AU - Aittokallio, Tero
AU - Wennerberg, Krister
AU - Heckman, Caroline A.
AU - Murumägi, Astrid
AU - Kallioniemi, Olli
PY - 2020
Y1 - 2020
U2 - 10.1038/s41375-020-0978-7
DO - 10.1038/s41375-020-0978-7
M3 - Journal article
C2 - 32678289
VL - 34
SP - 2780
EP - 2784
JO - Leukemia
JF - Leukemia
SN - 0887-6924
ER -
